OMNARIS

LOE Approaching

ciclesonide

NDANASALSPRAY
Approved
Nov 2007
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT02155881Phase 3Completed

Efficacy and Safety of Ciclesonide Nasal Spray in Participants With Seasonal Allergic Rhinitis (SAR) in Russia

Started Aug 2014
80 enrolled
Seasonal Allergic Rhinitis
NCT01455194Phase 3Completed

Effect of High Dose Ciclesonide on Asthma Control

Started Nov 2011
520 enrolled
Bronchial Asthma
NCT01369563N/ACompleted

Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

Started Aug 2011
1,630 enrolled
Perennial RhinitisSeasonal Rhinitis
NCT01430260Phase 4Completed

Omnaris Versus Levocetirizine Phase 4 Study

Started Jan 2011
349 enrolled
Allergic Rhinitis
NCT00826969Phase 4Completed

Ciclesonide for the Treatment of Airway Hyperresponsiveness

Started Sep 2008
64 enrolled
Asthma